Kinga Michalina Krawiec

Dr. Kinga Michalina Krawiec

Medical University of Lodz, Łódź, Łódzkie, Poland
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
KKKinga Michalina Krawiec
Kinga Michalina Krawiec
PSPiotr Strzałka
Piotr Strzałka
MCMagdalena Czemerska
Magdalena Czemerska
AWAneta Wiśnik
Aneta Wiśnik
IZIzabela Zawlik
Izabela Zawlik
APAgnieszka Pluta
Agnieszka Pluta
More than 97% of patients with acute myeloid leukemia (AML) demonstrate genetic mutations leading to excessive proliferation combined with the evasion of regulated cell death (RCD). The most prominent and well-defined form of RCD is apoptosis, which serves as a defense mechanism against the emergence of cancer cells. Apoptosis is regulated in part by the BCL-2 family of pro- and anti-apoptotic proteins, whose balance can significantly determine cell survival. Apoptosis evasion plays a key role in tumorigenesis and drug resistance, and thus in the development and progression of AML. Research on the structural and biochemical aspects of apoptosis proteins and their regulators offers promise for new classes of targeted therapies and strategies for therapeutic intervention. This review provides a comprehensive overview of current AML treatment options related to the mechanism of apoptosis, particularly its mitochondrial pathway, and other promising concepts such as neddylation. It pays particular attention to clinically-relevant aspects of current and future AML treatment approaches, highlighting the molecular basis of individual therapies.

11 April 2025 in Genes
Verified
Journal Article
Open access
PDF file
AWAneta Wiśnik
Aneta Wiśnik
DJDariusz Jarych
Dariusz Jarych
KKKinga Michalina Krawiec
Kinga Michalina Krawiec
PSPiotr Strzałka
Piotr Strzałka
NPNatalia Potocka
Natalia Potocka
IZIzabela Zawlik
Izabela Zawlik
MicroRNA (miRNA), a significant class of regulatory non-coding RNA (ncRNA), can regulate the expression of numerous protein-coding messenger RNAs (mRNAs). miRNA plays an important part in shaping the human transcriptome. So far, in the human genome, about 2500 miRNAs have been found. Acute myeloid leukemia (AML) belongs to a malignant clonal disorder of hematopoietic stem cells and is characterized by the uncontrolled clonal proliferation of abnormal progenitor cells in the bone marrow and blood. For the past several years, significant scientific attention has been attracted to the role of miRNAs in AML, since alterations in the expression levels of miRNAs may contribute to AML development. This review describes the main functions of non-coding RNA classes and presents miRNA biogenesis. This study aims to review recent reports about altered microRNA expression and their influence on AML cell survival, cell cycle, and apoptotic potential. Additionally, it summarizes the correlations between miRNAs and their target mRNAs in AML and outlines the role of particular miRNAs in AML subtypes according to ELN recommendations.

17 March 2025 in Cancers
Verified
Journal Article
Open access
PDF file
PSPiotr Strzałka
Piotr Strzałka
KKKinga Michalina Krawiec
Kinga Michalina Krawiec
AWAneta Wiśnik
Aneta Wiśnik
DJDariusz Jarych
Dariusz Jarych
MCMagdalena Czemerska
Magdalena Czemerska
AWAgnieszka Wierzbowska
Agnieszka Wierzbowska
Acute myeloid leukemia (AML) corresponds to a heterogeneous group of clonal hematopoietic diseases, which are characterized by uncontrolled proliferation of malignant transformed myeloid precursors and their inability to differentiate into mature blood cells. The prognosis of AML depends on many variables, including the genetic features of the disease. Treatment outcomes, despite the introduction of new targeted therapies, are still unsatisfactory. Recently, there have been an increasing number of reports on enzymatic proteins of the sirtuin family and their potential importance in cancer in general. Sirtuins are a group of 7 (SIRT1-7) NAD+-dependent histone deacetylases with pleiotropic effects on metabolism, aging processes, and cell survival. They are not only responsible for post-translational modification of histones but also play various biochemical functions and interact with other proteins regulating cell survival, such as p53. Thus, their role in key mechanisms of tumorigenesis makes them a worthwhile topic in AML. Different sirtuins have been shown to act oppositely depending on the biological context, the mechanism of which requires further exploration. This review provides a comprehensive description of the significance and role of sirtuins in AML in light of the current state of knowledge. It focuses in particular on molecular mechanisms regulated by sirtuins and signaling pathways involved in leukemogenesis, as well as clinical aspects and potential therapeutic targets in AML.

1 January 2024 in Contemporary Oncology
Verified
Journal Article
Open access
KKKinga Michalina Krawiec
Kinga Michalina Krawiec
PSPiotr Strzałka
Piotr Strzałka
OROlga Racińska
Olga Racińska
MKMarcin Kędzior
Marcin Kędzior
HSHubert Sowul
Hubert Sowul
AWAgnieszka Wierzbowska
Agnieszka Wierzbowska
Introduction: Autologous hematopoietic stem cell transplantation (auto- HSCT) preceded by high-dose chemotherapy is a mainstay in relapsed/refractory lymphoma. The study aimed to compare the efficacy and adverse event profile between BEAM and Benda-EAM (BeEAM) regimens and to evaluate...

17 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
PSPiotr Strzałka
Piotr Strzałka
KKKinga Michalina Krawiec
Kinga Michalina Krawiec
AWAneta Wiśnik
Aneta Wiśnik
DJDariusz Jarych
Dariusz Jarych
MCMagdalena Czemerska
Magdalena Czemerska
AWAgnieszka Wierzbowska
Agnieszka Wierzbowska
Acute myeloid leukemia (AML) corresponds to a heterogeneous group of clonal hematopoietic diseases, which are characterized by uncontrolled proliferation of malignant transformed myeloid precursors and their inability to differentiate into mature blood cells. The prognosis of AML depends on many variables, including the genetic features of the disease. Treatment outcomes, despite the introduction of new targeted therapies, are still unsatisfactory. Recently, there have been an increasing number of reports on enzymatic proteins of the sirtuin family and their potential importance in cancer in general. Sirtuins are a group of 7 (SIRT1-7) NAD+-dependent histone deacetylases with pleiotropic effects on metabolism, aging processes, and cell survival. They are not only responsible for post-translational modification of histones but also play various biochemical functions and interact with other proteins regulating cell survival, such as p53. Thus, their role in key mechanisms of tumorigenesis makes them a worthwhile topic in AML. Different sirtuins have been shown to act oppositely depending on the biological context, the mechanism of which requires further exploration. This review provides a comprehensive description of the significance and role of sirtuins in AML in the light of the current state of knowledge. It focuses in particular on molecular mechanisms regulated by sirtuins and signaling pathways involved in leukemogenesis, as well as clinical aspects and potential therapeutic targets in AML.

30 April 2024 in Acta Haematologica Polonica
Verified
Journal Article
Open access
PDF file
KKKinga Michalina Krawiec
Kinga Michalina Krawiec
PSPiotr Strzałka
Piotr Strzałka
KSKamila Stańczak
Kamila Stańczak
MCMagdalena Czemerska
Magdalena Czemerska
ASAnna Szmigielska
Anna Szmigielska
APAgnieszka Pluta
Agnieszka Pluta
Introduction: Infections are one of the main causes of death after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Material and methods: We conducted a single-center retrospective analysis of colonization and infection epidemiology in 44 patients who underwent matched related donor (MRD) allo-HSCT between 2012 and 2022. Results: Colonization was observed in 84.1% of patients before allo-HSCT. The most common location was the anus, colonized in 55.4% of patients, mostly by Klebsiella pneumoniae ESBL (+) — 28.6%. Multi-drug resistant bacteria (MDR) accounted for 50.7% of positive colonization cultures before allo-HSCT. In the post-transplantation period (i.e. up to 100 days after allo-HSCT), infections occurred in 86.4% of patients. Bacteremia was observed in 47.7% of patients, mostly caused by methicillin-resistant coagulase-negative Staphylococcus epidermidis — 39.4%. Infection of the skin and soft tissue near the central line was found in 27.3% of patients, urinary tract infections in 56.8%, and gastrointestinal infections in 38.6%. Fungal infections were reported in 31.8%. MDR pathogens accounted for 58.1% of all infecting pathogens. The most common resistance was extended-spectrum beta-lactamase (ESBL), accounting for 50.8% of all MDR strains. Viral reactivations were detected in 29.5%. 59.5% of colonized patients developed an infection with the pathogen responsible for their previous colonization. Infections with such pathogens were significantly more frequent in colonized patients than with de novo pathogens (p = 0.04). Conclusions: Colonization evaluation can be an effective tool to identify patients with a high risk of developing post-transplant infections with the colonizing pathogen, potentially resulting in a prompter implementation of targeted treatment and improved infection outcome. Keywords: hematopoietic stem cell transplantation infections bacteremia